Ethnic variation in the incidence of ALS: A systematic review

Neurology

Volumn 68, Issue 13, 2007, Pages 1002-1007

  Cronin, Simon ^a   Hardiman, Orla ^a   Traynor, Bryan J ^b  

^a BEAUMONT HOSPITAL   (Ireland)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ASIAN; CAUCASIAN; DATA ANALYSIS; DNA POLYMORPHISM; ETHNICITY; HUMAN; INCIDENCE; MEDICAL LITERATURE; MORTALITY; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; UNITED STATES;

AFRICAN AMERICANS; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HISPANIC AMERICANS; HUMANS; INCIDENCE; MIDDLE AGED; PREVALENCE; UNITED STATES;

EID: 34147123804     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000258551.96893.6f     Document Type: Review

References (73)

1. Brooks BR. Clinical epidemiology of amyotrophic lateral sclerosis. In: Riggs JE, ed. Neuroepidemiology. Philadelphia: WB Saunders, 1996:399-420.
2. Chancellor AM, Warlow CP. Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry 1992;55:1106-1115.
3. Roman GC. Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis. J Neurol Neurosurg Psychiatry 1996;61:131-137.
4. Gwinn-Hardy K. Racial and ethnic influences on the expression of the genotype in neurodegenerative diseases. In: Cummings J, Hardy J, Poncet M, Christen Y, eds. Genotype-proteotype-phenotype relationships in neurodegenerative diseases. Berlin: Springer, 2005:25-36.
5. Greenway MJ, Andersen PM, Russ C, et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet 2006;38:411-413.
6. Van Vught PW, Sutedja NA, Veldink JH, et al. Lack of association between VEGF polymorphisms and ALS in a Dutch population. Neurology 2005;65:1643-1645.
7. Kanaha E, Zilber N. Changes in the incidence of amyotrophic lateral sclerosis in Israel. Arch Neurol 1984;41:157-160.
8. Moriwaka F, Okumura H, Tashiro K, et al. Motor neuron disease and past poliomyelitis. Geographic study in Hokkaido, the northern-most island of Japan. J Neurol 1993;240:13-16.
9. PARALS Piemonte and Valle d'Aosta Register for Amyotrophic Lateral Sclerosis. Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology 2001;56:239-244.
10. Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology 2002;59:280-282.
11. World Federation of Neurology Subcommittee on Motor Neuron Disease. El Escorial Criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124:(suppl):98-107.
12. Daly L, Bourke GJ. Interpretation and uses of medical statistics. Oxford: Blackwell Science, 2000.
13. Logroscino G, Beghi E, Zoccolella S, et al. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry 2005;76:1094-1098.
14. Dietrich-Neto F, Callegaro D, Dias-Tosta E, et al. Amyotrophic lateral sclerosis in Brazil: 1998 national survey. Ar Qneuropsiquiatr 2000;58:607-615.
15. Vazquez C, Ketzoian C, Legnani C, Rega I, Sanchez N, Perna T. Epidemiology of ALS in Uruguay. Incidence, prevalence and risk factors. Neuroepidemiology 2006;26:182.
16. Galdames D, Aguilera L, Riveros JM, Arce C. [Epidemiology of amyotrophic lateral sclerosis in Santiago. A retrospective study (author's transl)]. Rev Med Chil 1980;108:435-439.
17. Olivares L, Esteban ES, Alter M. Mexican "resistance" to amyotrophic lateral sclerosis. Arch Neurol 1972;27:397-402.
18. Moraes L, Goldbaum M, Silva HCA, Callegaro D. Incidence rate of amyotrophic lateral sclerosis (ALS) in Sao Paulo city, Brazil, 1991-1997. Ar Qneuropsiquiatr 1998;56:343-.
19. McGuire V, Longstreth WT Jr, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington State. Neurology 1996;47:571-573.
20. Hudson AJ, Davenport A, Hader WJ. The incidence of amyotrophic lateral sclerosis in southwestern Ontario, Canada. Neurology 1986;36:1524-1528.
21. Annegers JF, Appel S, Lee JR, Perkins P. Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988. Arch Neurol 1991;48:589-593.
22. Fong KY, Yu YL, Chan YW, et al. Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture. Neuroepidemiology 1996;15:239-245.
23. Chen KM, Yase Y, eds. Amyotrophic lateral sclerosis in Asia and Oceania. New Zealand: National Taiwan University, 1984:199-238.
24. Matsumoto N, Worth RM, Kurland LT, Okazaki H. Epidemiologic study of amyotrophic lateral sclerosis in Hawaii. Identification of high incidence among Filipino men. Neurology 1972;22:934-940.
25. Radhakrishnan K, Ashok PP, Sridharan R, Mousa ME. Descriptive epidemiology of motor neuron disease in Benghazi, Libya. Neuroepidemiology 1986;5:47-54.
26. Osuntokun BO, Adeuja AO, Schoenberg BS, et al. Neurological disorders in Nigerian Africans: a community-based study. Acta Neurol Scand 1987;75:13-21.
27. Tekle-Haimanot R, Abebe M, Gebre-Mariam A, et al. Community-based study of neurological disorders in rural central Ethiopia. Neuroepidemiology 1990;9:263-277.
28. Khondkarian OA, Bunina TL. On the features of the clinical picture and course of amyotrophic lateral sclerosis. Zh Nevropatol Psikhiatr Im S S Korsakova 1966;66:1457-1461.
29. Ahlstrom G, Gunnarsson LG, Leissner P, Sjoden PO. Epidemiology of neuromuscular diseases, including the postpolio sequelae, in a Swedish county. Neuroepidemiology 1993;12:262-269.
30. Murros K, Fogelholm R. Amyotrophic lateral sclerosis in Middle-Finland: an epidemiological study. Acta Neurol Scand 1983;67:41-47.
31. The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry 1992;55:536-541.
32. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 1999;52:504-509.
33. Mitchell JD, Gatrell AC, Al-Hamad A, Davies RB, Batterby G. Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and south Cumbria. J Neurol Neurosurg Psychiatry 1998;65:842-847.
34. Forsgren L, Almay BG, Holmgren G, Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand 1983;68:20-29.
35. Tysnes OB, Vollset SE, Aarli JA. Epidemiology of amyotrophic lateral sclerosis in Hordaland county, western Norway. Acta Neurol Scand 1991;83:280-285.
36. Jokelainen M. Amyotrophic lateral sclerosis in Finland. I: An epidemiologic study. Acta Neurol Scand 1977;56:185-193.
37. Hojer-Pedersen E, Christensen PB, Jensen NB. Incidence and prevalence of motor neuron disease in two Danish counties. Neuroepidemiology 1989;8:151-159.
38. Brewis M, Poskanzer DC, Rolland C, Miller H. Neurological disease in an English city. Acta Neurol Scand 1966;42(suppl):1-89
39. Kristensen O, Melgaard B. Motor neuron disease. Prognosis and epidemiology. Acta Neurol Scand 1977;56:299-308.
40. Gudmundsson KR. The prevalence of some neurological diseases in Iceland. Acta Neurol Scand 1968;44:57-69.
41. Mochecka-Thoelke A. Clinical pattern and epidemiological analysis of amyotrophic lateral sclerosis in the Lodz region in 1980-1986. Neurol Neurochir Pol 1994;28:189-194.
42. Gross-Paju K, Oopik M, Luus SM, et al. Motor neurone disease in South Estonia. Diagnosis and incidence rate. Acta Neurol Scand 1998;98:22-28.
43. Argyriou AA, Polychronopoulos P, Papapetropoulos S, et al. Clinical and epidemiological features of motor neuron disease in south-western Greece. Acta Neurol Scand 2005;111:108-113.
44. Potemkowski A, Honczarenko K, Fabian A. [Clinical course and epidemiological analysis of amyotrophic lateral sclerosis in Szczecin in 1986-1995]. Neurol Neurochir Pol 1999;33:71-78.
45. Cendrowski W, Wender M, Owsianowski M.. [Epidemiological analysis of amyotrophic lateral sclerosis in Poznan District in Western Poland] Acta Neurol Scand 1970;46:609-617.
46. Alcaz S, Jarebinski M, Pekmezovic T, Stevic-Marinkovic Z, Pavlovic S, Apostolski S . Epidemiological and clinical characteristics of ALS in Belgrade, Yugoslavia. Acta Neurol Scand 1996;94:264-268.
47. Chio A, Brignolio F, Meineri P, Rosso MG, Schiffer D. Epidemiology of motor neuron disease in two Italian provinces. Analysis of secular trend and geographic distribution. Neuroepidemiology 1989;8:79-86.
48. Lopez-Vega JM, Calleja J, Combarros O, Polo JM, Berciano J. Motor neuron disease in Cantabria. Acta Neurol Scand 1988;77:1-5.
49. Granieri E, Carreras M, Tola R, et al. Motor neuron disease in the province of Ferrara, Italy, in 1964-1982. Neurology 1988;38:1604-1608.
50. Bracco L, Antuono P, Amaducci L. Study of epidemiological and etiological factors of amyotrophic lateral sclerosis in the province of Florence, Italy. Acta Neurol Scand 1979;60:112-124.
51. Leone M, Chio A, Mortara P, Rosso MG, Schiffer D. Motor neuron disease in the Province of Turin, Italy, 1971-1980. Acta Neurol Scand 1983;68:316-327.
52. Rosati G, Pinna L, Granieri E, et al. Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, Southern Italy. Acta Neurol Scand 1977;55:231-244.
53. De Domenico P, Malara CE, Marabello L, et al. Amyotrophic lateral sclerosis: an epidemiological study in the Province of Messina, Italy, 1976-1985. Neuroepidemiology 1988;7:152-158.
54. Yoshida S, Mulder DW, Kurland LT, Chu CP, Okazaki H. Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984. Neuroepidemiology 1986;5:61-70.
55. McCluskey K, McCluskey L. Racial disparity in mortality from ALS/MND in US African Americans. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5(suppl):73-78.
56. Noonan CW, White MC, Thurman D, Wong LW. Temporal and geographic variation in United States motor neuron disease mortality, 1969-1998. Neurology 2005;64:1215-1221.
57. Leone M, Chandra V, Schoenberg BS. Motor neuron disease in the United States, 1971 and 1973-1978: patterns of mortality and associated conditions at the time of death. Neurology 1987;37:1339-1343.
58. Elian M, Dean G. Motor neuron disease and multiple sclerosis among immigrants to England from the Indian subcontinent, the Caribbean, and east and west Africa. J Neurol Neurosurg Psychiatry 1993;56:454-457.
59. Kahana E, Alter M, Feldman S. Amyotrophic lateral sclerosis: a population study. J Neurol 1976;212:205-213.
60. Chio A, Cucatto A, Calvo A, Terreni AA, Magnani C, Schiffer D. Amyotrophic lateral sclerosis among the migrant population to Piemonte, northwestern Italy. J Neurol 1999;246:175-180.
61. Dean G, Elian M. Motor neuron disease and multiple sclerosis mortality in Australia, New Zealand and South Africa compared with England and Wales. J Neurol Neurosurg Psychiatry 1993;56:633-637.
62. Veiga-Cabo J, Almazan-Isla J, Sendra-Gutierrez JM, de Pedro-Cuesta J. Differential features of motor neuron disease mortality in Spain. Int J Epidemiol 1997;26:1024-1032.
63. Neilson S, Robinson I, Hunter M. Static and dynamic models of interdisease competition: past and projected mortality from amyotrophic lateral sclerosis and multiple sclerosis. Mech Ageing Dev 1993;66:223-241.
64. Martyn CN, Barker DJP, Osmond C. Motoneuron disease and past poliomyelitis in England and Wales. Lancet 1988;1:1319-1322.
65. Okamoto K, Kobashi G, Washio M, et al. Descriptive epidemiology of amyotrophic lateral sclerosis in Japan, 1995-2001. J Epidemiol 2005;15:20-23.
66. Lima JMB, Mesquita N, Duro LAA, Furtado AB. Epidemiological aspects of amyotrophic lateral sclerosis in Rio de Janeiro city. Rev Bras Neurol 1983;19:75-78.
67. Kondo K, Tsubaki T. Changing mortality patterns of motor neuron disease in Japan. J Neurol Sci 1977;32:411-424.
68. Gomes MM. Envelhecimento e o aumento das doencas amiotroficas: epidemiologia das doencas (cronicas) das celulas do corno anterior da medulla. Ar Qbras Med 1991;65:589-594.
69. Borak J, Fiellin M, Chemerynski S. Who is Hispanic? Implications for epidemiologic research in the United States. Epidemiology 2004;15:240-244.
70. Schoenberg BS, Anderson DW, Haerer AF. Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi. Neurology 1985;35:841-845.
71. Lilienfeld DE, Perl DP. Projected neurodegenerative disease mortality among minorities in the United States, 1990-2040. Neuroepidemiology 1994;13:179-186.
72. Gompertz B.. On the nature of the function expressive of the law of human mortality. Philos Trans R Soc Lond 1825;115:513-585.
73. Neilson S, Robinson I, Alperovitch A.. Rising amyotrophic lateral sclerosis mortality in France 1968-1990: increased life expectancy and inter-disease competition as an explanation. J Neurol 1994;241:448-455.